Radiopharmaceuticals are increasingly central to modern diagnostic imaging and targeted therapy. These agents contain radioactive isotopes that emit detectable radiation, enabling visualisation of physiological and molecular processes. Technetium-99m remains one of the most widely used isotopes in SPECT imaging, supporting cardiac, pulmonary and oncological assessment. Fluorine-18 fluorodeoxyglucose underpins PET imaging by highlighting tissues with high glucose metabolism, transforming cancer detection and staging. Gallium-68–labelled compounds allow precise localisation of neuroendocrine tumours, while therapeutic agents such as lutetium-177–based treatments and radium-223 deliver targeted radiation to malignant tissue. Iodine-131 continues to play a key role in the management of thyroid disease. Ongoing research is expanding this field, advancing precision diagnosis and personalised treatment strategies in contemporary healthcare.
home »
By
FLYRCADO, a radiopharmaceutical agent employed in PET myocardial perfusion imaging, provides accurate quantification of myocardial blood flow, enhancing diagnostic confidence.
By
Zevalin, combining monoclonal antibodies and radiation, offers hope against refractory B-cell non-Hodgkin’s lymphoma with targeted therapy.
By
Yttrium-90 chloride is pivotal in radioimmunotherapy, targeting cancer cells precisely while minimizing damage to surrounding tissues.
By
Xenon-133 is pivotal for imaging lungs and assessing brain flow, enhancing diagnoses in modern medicine.
By
Thallium-201 chloride is pivotal in myocardial perfusion imaging, diagnosing ischemic heart disease, and assessing myocardial viability.
By
Lymphoseek offers targeted, efficient sentinel lymph node mapping, improving cancer staging and reducing surgical morbidity.
By
Technetium-99m tetrofosmin is vital for detecting coronary artery disease via myocardial perfusion imaging, enhancing cardiac care.
By
Technetium-99m sulfur colloid provides critical diagnostics for liver, spleen, and bone marrow using targeted nuclear imaging.
By
Technetium-99m succimer is pivotal for renal imaging, enhancing diagnostics with minimal invasiveness and low radiation.
By
Technetium-99m sodium pertechnetate is pivotal for brain, thyroid, cardiac imaging, and cancer detection in nuclear medicine.
By
Technetium-99m Sestamibi revolutionises cardiac care by precisely mapping blood flow in diagnosing coronary artery disease.
By
Technetium-99m UltraTag RBCs enhance blood pool imaging and precisely localize gastrointestinal bleeding in non-invasive diagnostic procedures.
By
Technetium-99m pyrophosphate is pivotal for diagnosing bone diseases and cardiac amyloidosis through targeted radiopharmaceutical imaging.
By
Technetium-99m pentetate revolutionises brain and kidney imaging by providing crucial non-invasive insights into their function.
By
Technescan, utilising Technetium-99m oxidronate, revolutionises bone imaging by highlighting metabolic activity with high sensitivity and precision.
By
Tc-99m MAG3 scintigraphy offers unparalleled insights into renal function, aiding diagnosis and management of kidney disorders.
By
Technetium-99m medronate is vital in nuclear medicine for precise bone imaging and detecting osteogenesis abnormalities.
By
Technetium-99m Mebrofenin is pivotal for hepatobiliary imaging, assessing liver function, gallbladder diseases, and biliary obstructions.
By
Technetium-99m Macroaggregated Albumin serves a key role in assessing pulmonary vascular integrity, supporting targeted therapeutic measures.
By
Technetium-99m exametazime (Ceretec) is a pivotal radiopharmaceutical in nuclear medicine, revolutionising brain imaging with high precision and reliability.
By
Posluma (Flotufolastat F-18) offers precise PET imaging for detecting PSMA-positive prostate cancer lesions.
By
Technetium-99m bicisate (Neurolite) facilitates stroke diagnosis by enabling cerebral perfusion imaging, aiding in locating affected brain regions.
By
Strontium-89 chloride: a potent palliative for metastatic bone cancer-induced pain, through calcium-mimicking, localized beta radiation, ensuring effective, safer pain relief.
By
Rubidium-82 enhances PET imaging, aiding myocardial perfusion evaluation, crucial for diagnosing coronary artery disease efficiently.
By
Radium-223 dichloride, a targeted alpha therapy, effectively treats castration-resistant prostate cancer with bone metastases, improving patients’ overall survival.
By
Nitrogen-13 Ammonia, used in cardiac PET imaging, assesses myocardial perfusion, aiding diagnosis and treatment of heart diseases.
By
The Molybdenum-99 Generator crucially produces Technetium-99m for medical imaging, through radioactive decay, aiding numerous diagnostic procedures globally.
By
Lutetium-177 Vipivotide Tetraxetan – Pluvicto: Radiopharmaceutical for targeted cancer therapy. Innovative, promising, precise, advanced, therapeutic.
By
Lutetium-177 Dotatate selectively binds to SSTRs on NET cells, delivering targeted radiation, minimizing collateral damage, and reducing side effects.
By
Iodine-131 sodium iodide, a radioactive isotope, is used in diagnosing and treating thyroid disorders and specific cancer therapies.
